18093218. Sepsis Monitoring Device simplified abstract (Becton, Dickinson and Company)

From WikiPatents
Jump to navigation Jump to search

Sepsis Monitoring Device

Organization Name

Becton, Dickinson and Company

Inventor(s)

Shishir Prasad of Ramsey NJ (US)

Prasad Govindaraj of Coimbatore (IN)

Sridhaar Nandakumar of Chennai (IN)

Balaji Kannan of Chennai (IN)

Manish Kumar of Bengaluru (IN)

Ajay Suryavanshi of Pune (IN)

Sepsis Monitoring Device - A simplified explanation of the abstract

This abstract first appeared for US patent application 18093218 titled 'Sepsis Monitoring Device

The patent application describes a sepsis monitoring device that includes a patch with microneedles to collect interstitial fluid for detecting sepsis biomarkers.

  • Patch with microneedles arranged on one side to penetrate human skin and collect interstitial fluid.
  • Sensor in fluid communication with microneedles to detect sepsis biomarkers in the collected fluid.
  • Designed to monitor sepsis condition or onset of sepsis by analyzing interstitial fluid.
  • Provides a non-invasive method for continuous monitoring of sepsis biomarkers.
  • Offers a potential breakthrough in early detection and management of sepsis.

Potential Applications: - Medical monitoring devices for sepsis patients. - Hospital settings for real-time sepsis detection. - Research purposes in studying sepsis biomarkers.

Problems Solved: - Early detection of sepsis. - Continuous monitoring of sepsis biomarkers. - Non-invasive method for fluid collection.

Benefits: - Early intervention in sepsis cases. - Improved patient outcomes. - Real-time monitoring for timely treatment.

Commercial Applications: Title: "Innovative Sepsis Monitoring Device for Improved Patient Care" This technology can be utilized in hospitals, clinics, and research facilities for sepsis monitoring, potentially leading to improved patient care outcomes and reduced healthcare costs.

Questions about Sepsis Monitoring Device: 1. How does the device collect interstitial fluid for analysis? The device uses microneedles on a patch to penetrate the skin and collect interstitial fluid for biomarker detection.

2. What are the potential benefits of early sepsis detection with this device? Early sepsis detection can lead to timely treatment, improved patient outcomes, and reduced healthcare costs.


Original Abstract Submitted

Provided herein is a sepsis monitoring device including: a patch having a first side and an opposing second side, where the second side is adapted to adhere to human skin; a plurality of microneedles arranged on the second side of the patch and configured to penetrate the human skin to a depth sufficient to collect interstitial fluid when the patch is adhered to the human skin, where the plurality of microneedles are configured to collect the interstitial fluid when the patch is adhered to the human skin; and a sensor in fluid communication with the plurality of microneedles and configured to detect a biomarker indicating a sepsis condition or an onset of the sepsis condition when contacted with the interstitial fluid collected by the plurality of microneedles.